Literature DB >> 2558932

Proglucagon expression, posttranslational processing and secretion in SV40-transformed islet cells.

K I Shennan1, J J Holst, K Docherty.   

Abstract

HIT T15 is a B cell line derived from SV40 transformation of hamster islets. We describe here a HIT T15 variant, designated HIT T15-G, which appears to have evolved spontaneously and which expresses glucagon. Regulation of glucagon gene expression, posttranslational processing of proglucagon, and secretion of glucagon were studied in this cell line. Glucagon mRNA concentrations were increased approx. 2-fold following incubation of cells for 18 h in 10 microM forskolin but were unaffected by treatment with a phorbol ester (12-O-tetradecanoylphorbol 13-acetate; TPA) or with ionomycin. Proglucagon was processed to glucagon, and several large molecular weight forms of GLP-I and GLP-II which may include the major proglucagon fragment (MPF). The secretion of glucagon was stimulated by forskolin (5-fold), adrenalin (2-fold), arginine (3-fold) and KCl (2-fold) but was unaffected by glucose. These results suggest that the HIT T15-G cells may represent a less differentiated form of the parental HIT T15 cell line in which A cell phenotype is dominant but not complete.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558932     DOI: 10.1016/0303-7207(89)90234-7

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  2 in total

1.  Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation.

Authors:  Oleg G Chepurny; George G Holz
Journal:  Cell Tissue Res       Date:  2002-01-08       Impact factor: 5.249

2.  Expression of insulin receptor on clonal pancreatic alpha cells and its possible role for insulin-stimulated negative regulation of glucagon secretion.

Authors:  K Kisanuki; H Kishikawa; E Araki; T Shirotani; M Uehara; S Isami; S Ura; H Jinnouchi; N Miyamura; M Shichiri
Journal:  Diabetologia       Date:  1995-04       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.